1.A case report of pyloric intussusception secondary to helicobacter pylori hyperplastic polyps
Wan Najmi Wan Daud ; Noorfizura Ahmad ; Wan Anna Mohd Fahmi
The Medical Journal of Malaysia 2016;71(1):35-36
We report a middle age man who presented with intermittent
vomiting and loss of weight.
Oesophagogastroduodenoscopy showed numerous antral
hyperplastic polyps with inaccessible duodenum. Contrast
enhanced computed topography demonstrated a classical
target sign of intussusception. This finding was later
confirmed at laparotomy. This rare presentation and
management strategy is discussed.
Polyps
2.Application of 3C bolus wizard on controlling postprandial glucose in diabetic patients
Lifang YANG ; Anna WAN ; Jing GUO ; Qing WAN ; Fei XIAO
Modern Clinical Nursing 2014;(12):32-34
ObjectiveTo explore the influence of 3C bolus wizard on postprandial glucose levels in diabetic patients. MethodFifty-eight patients with type 2 diabetes in our hospital were monitored with continuous glucose monitoring system(CGMS), continuous subcutaneous insulin infusion(CSII)and CareLink(3C for short)for 6 days.The function of “3C” bolus wizard was applied during treatment and all the patients were given dietary nursing and health education.The glucose level was observed.ResultThe level of P2hBG of the 58 patients was between 6.4~10.7mmol/L in 3~6 days.ConclusionsBolus wizard plays an important role in “3C” treatment.It can make the postprandial glucose of patients satisfactorily controlled in a short time only to avoid insulin hypoglycemia because of large doses of insulin.At the same time,health education on patients can achieve remarkable results as well.
3.Is Frailty a Modifiable Risk Factor of Future Adverse Outcomes in Elderly Patients with Incident End-Stage Renal Disease?.
Sung Woo LEE ; Anna LEE ; Mi Yeon YU ; Sun wook KIM ; Kwang il KIM ; Ki Young NA ; Dong Wan CHAE ; Cheol ho KIM ; Ho Jun CHIN
Journal of Korean Medical Science 2017;32(11):1800-1806
Little is known about the clinical significance of frailty and changes of frailty after dialysis initiation in elderly patients with end-stage renal disease (ESRD). We prospectively enrolled 46 elderly patients with incident ESRD at a dialysis center of a tertiary hospital between May 2013 and March 2015. Frailty was assessed by using a comprehensive geriatric assessment protocol and defined as a multidimensional frailty score of ≥ 10. The main outcome was the composite of all-cause death or cardiovascular hospitalization, as determined in June 2016. The median age of the 46 participants was 71.5 years, and 63.0% of them were men. During the median 17.7 months follow-up, the rate of composite outcome was 17.4%. In multivariate logistic regression analysis, after adjusting for age, sex, diabetes, body mass index (BMI), and time of predialytic nephrologic care, female sex, and increased BMI were associated with increased and decreased odds of frailty, respectively. In multivariate Cox proportional hazards analysis, after adjusting for age, sex, diabetes, BMI, and time of predialytic nephrologic care, frailty was significantly associated with the composite adverse outcome. In repeated frailty assessments, the multidimensional frailty score significantly improved 12 months after the initiation of dialysis, which largely relied on improved nutrition. Therefore, frailty needs to be assessed for risk stratification in elderly patients with incident ESRD.
Aged*
;
Body Mass Index
;
Dialysis
;
Female
;
Follow-Up Studies
;
Geriatric Assessment
;
Hospitalization
;
Humans
;
Kidney Failure, Chronic*
;
Logistic Models
;
Male
;
Malnutrition
;
Prospective Studies
;
Risk Factors*
;
Tertiary Care Centers
4.Clinical Usefulness of Unenhanced Computed Tomography in Patients with Acute Pyelonephritis.
Anna LEE ; Hyo Cheol KIM ; Sung Il HWANG ; Ho Jun CHIN ; Ki Young NA ; Dong Wan CHAE ; Sejoong KIM
Journal of Korean Medical Science 2018;33(38):e236-
BACKGROUND: Unenhanced computed tomography (UCT) may be useful for evaluating acute pyelonephritis; however, no study has compared UCT with enhanced computed tomography (ECT) as a diagnostic tool. We evaluated a clinical usefulness of UCT versus ECT in acute pyelonephritis (APN). METHODS: We reviewed the clinical and radiological data from 183 APN-suspected patients who underwent UCT and ECT simultaneously at emergency room (ER) over a two-year period. Demographic, clinical parameters and computed tomography (CT) parameters of 149 patients were compared. RESULTS: The average patient age was 61.2 (± 10) years: 31 patients were men. Ninety-nine (66.4%) patients showed stones (18.7%), perinephric infiltration (56%), swelling (21%), and hydronephrosis (6.7%) on UCT. Seventeen patients (11.4%) had an atypical clinical course, requiring additional tests for accurate diagnosis. In 7 patients UCT and ECT results did not differ; in 10 patients, the diagnosis changed on ECT. On ECT, 112/149 (75.2%) patients had stones (16.7%), perinephric infiltrations (57%), swelling (21%), and hydronephrosis (6.7%); 62.5% showed parenchymal involvement: 34 (22.8%) patients had no abnormal ECT findings. APN CT findings are similar on stone, perinephric infiltration, swelling and hydronephrosis on both CTs. Twelve patients (8.0%) had an abnormal ECT finding, i.e., low-grade (1 and 2) parenchymal involvement. Six (4%) patients developed contrast-induced acute kidney injury within 2 days after ECT. CONCLUSION: We demonstrate that UCT is not inferior to ECT as an initial tool for evaluating APN for screening nephrolithiasis and hydronephrosis without the risk of contrast-induced acute kidney injury (CIAKI). However, patients with an atypical clinical course may still need ECT.
Acute Kidney Injury
;
Diagnosis
;
Emergency Service, Hospital
;
Humans
;
Hydronephrosis
;
Male
;
Mass Screening
;
Nephrolithiasis
;
Pyelonephritis*
5.Effects of Dietary Habits on General and Abdominal Obesity in Community-dwelling Patients with Schizophrenia
Mina KIM ; Soo Jin YANG ; Hyang Hee KIM ; Anna JO ; Min JHON ; Ju-Yeon LEE ; Seung-Hyung RYU ; Jae-Min KIM ; Young-Ran KWEON ; Sung-Wan KIM
Clinical Psychopharmacology and Neuroscience 2023;21(1):68-76
Objective:
To investigate the effects of dietary habits on general and abdominal obesity in community-dwelling patients with schizophrenia spectrum disorder according to sex.
Methods:
A total of 270 patients with schizophrenia spectrum disorder registered at mental health welfare centers and rehabilitation facilities were recruited. General obesity was defined as a body mass index ≥ 30 kg/m 2 , and abdominal obesity was defined as a waist circumstance ≥ 90 cm in men and ≥ 85 cm in women. Dietary habits were evaluated using dietary guidelines published by the Korean Ministry of Health and Welfare. Demographic and clinical characteristics along with dietary habits and information related to obesity were collected. Factors related to obesity were evaluated separately by sex.
Results:
Dietary habits differed according to sex, in that scores for healthy eating habits were lower in men than in women. In men, the prevalences of general and abdominal obesity were 17.0% and 37.3%, respectively. In women, the prevalences of general and abdominal obesity were 23.1% and 38.5%, respectively. Regression analysis showed that the scores of regular eating habits were negatively associated with general and abdominal obesity in men, and the scores of healthy eating habits were negatively associated with general and abdominal obesity in women.
Conclusion
Among patients with schizophrenia, regular eating habits might reduce the risk of obesity in men, and healthy eating habits might reduce the risk of obesity in women. Nutrition education should be provided to community-dwelling patients with schizophrenia to prevent obesity in this population.
6.Effectiveness of Switching to Long-acting Injectable Aripiprazole in Patients with Recent-onset and Chronic Schizophrenia
Sung-Wan KIM ; Bong-Ju LEE ; Eun-Jin CHEON ; Seung-Hee WON ; Anna JO ; Jae-Min KIM ; Young-Chul CHUNG
Clinical Psychopharmacology and Neuroscience 2023;21(1):57-67
Objective:
This study investigated the effectiveness of switching to once-monthly long-acting injectable (LAI) aripiprazole from other second-generation antipsychotics including LAI paliperidone palmitate in both recent-onset and chronic schizophrenia patients.
Methods:
This was a 24-week prospective, open-label, flexible dose-switching study in patients with schizophrenia. Scores on the Positive and Negative Syndrome Scale (PANSS), Personal and Social Performance (PSP) scale, Clinical Global Impression (CGI), Subjective Well-being Under Neuroleptics−Short Form (SWN-K), and a computerized emotional recognition test (ERT) were evaluated. Subjects were divided into two groups (recent onset and chronic) based on 5 years’ duration of the illness.
Results:
Among the 82 patients participating, 67 (81.7%) completed the 24-week study. The discontinuation rate after switching to LAI aripiprazole did not differ according to clinical characteristics including type of previous antipsychotics. Scores on the PANSS, PSP, SWN-K, CGI, and ERT were significantly improved after a switch to LAI aripiprazole without exacerbation of metabolic parameters and bodyweight. The improvements in the PANSS, PSP, and CGI scores were significantly greater in patients with recent-onset than in those with chronic schizophrenia; the improvement in metabolic parameters was significantly greater in the latter group.
Conclusion
High rates of successful switching to LAI aripiprazole from other antipsychotics suggest its good tolerability and effectiveness. Improvements in psychopathology and social functioning were more evident in patients with recent-onset schizophrenia, and improvements in metabolic abnormalities were more prominent in patients with chronic schizophrenia.
7.Crizotinib versus Chemotherapy in Asian Patients with ALK-Positive Advanced Non-small Cell Lung Cancer.
Makoto NISHIO ; Dong Wan KIM ; Yi Long WU ; Kazuhiko NAKAGAWA ; Benjamin J SOLOMON ; Alice T SHAW ; Satoshi HASHIGAKI ; Emiko OHKI ; Tiziana USARI ; Jolanda PAOLINI ; Anna POLLI ; Keith D WILNER ; Tony MOK
Cancer Research and Treatment 2018;50(3):691-700
PURPOSE: Crizotinib has demonstrated superior progression-free survival (PFS) and objective response rates (ORRs) versus chemotherapy in previously treated and untreated patients with anaplastic lymphoma kinase (ALK)-positive advanced non-small cell lung cancer (NSCLC). We report the safety and efficacy of crizotinib in Asian subpopulations of two global phase III trials. MATERIALS AND METHODS: This analysis evaluated previously treated and untreated patients in two randomized, open-label phase III trials of crizotinib versus chemotherapy in ALK-positive advanced NSCLC in second-line (PROFILE 1007) and first-line settings (PROFILE 1014). Efficacy and safety were analyzed by race in the intention-to-treat and “as-treated” populations for efficacy and safety endpoints, respectively. RESULTS: In previously treated (n=157) and untreated (n=157) Asian patients, PFS was statistically significantly longer with crizotinib versus chemotherapy (hazard ratio for PFS, 0.526; 95% confidence interval, 0.363 to 0.762; p < 0.001 and hazard ratio, 0.442; 95% confidence interval, 0.302 to 0.648; p < 0.001, respectively). Similar antitumor activity was seen in the non-Asian and overall populations. ORRs were statistically significantly higher with crizotinib versus chemotherapy in both Asian and non-Asian previously treated and untreated patients (p < 0.05). The most common treatment-emergent adverse events (any grade)with crizotinib were vision disorder, diarrhea, and nausea, which were observed at a comparable incidence across Asian and non-Asian populations, irrespective of previous treatment status. Most adverse events were mild to moderate in severity. CONCLUSION: These data, currently the only analysis showing Asian and non-Asian populations in the same study, support the efficacy and safety of crizotinib in Asian patients with previously treated or untreated ALK-positive advanced NSCLC.
Asia
;
Asian Continental Ancestry Group*
;
Carboplatin
;
Carcinoma, Non-Small-Cell Lung*
;
Cisplatin
;
Continental Population Groups
;
Diarrhea
;
Disease-Free Survival
;
Drug Therapy*
;
Humans
;
Incidence
;
Lymphoma
;
Nausea
;
Pemetrexed
;
Phosphotransferases
;
Vision Disorders
8.Metastatic Pleomorphic Adenoma in the infratemporal fossa and neck following total parotidectomy after 30 years
Danny Kit Chung Wong ; Nur Sabrina Mohamad ; Siti Shakinah Sobri ; Wan Anna Md Amin ; Zulkifli Yusof
The Medical Journal of Malaysia 2019;74(2):184-186
Metastasising pleomorphic adenoma is rare and may occur
years after surgical excision of a pleomorphic adenoma
(PA). We present a 61-year-old woman with a right
infratemporal PA with metastases to the cervical lymph
nodes after 30 years following a total parotidectomy. She
was treated successfully with a resection of the tumour with
combined neck and mandibulotomy approach along with
postoperative radiotherapy given subsequently.
9.Acute Mycoplasma Pneumoniae Encephalitis in an Adult
Leong Wan Yi ; Abdul Hanif Khan Yusof Khan ; Janudin Baharin ; Wei Chao Loh ; Anna Misya&rsquo ; il Abdul Rashid ; Wan Aliaa Wan Sulaiman ; Fan Kee Hoo ; Hamidon Basri ; Laila Mastura Ahmad Apandi ; Liyana Najwa Inche Mat
Malaysian Journal of Medicine and Health Sciences 2022;18(No.5):222-224
Mycoplasma pneumonia is an atypical bacterium that causes mild respiratory tract infections, especially in the upper
respiratory system. Mycoplasma pneumoniae infection is infrequently associated with various CNS manifestations
such as encephalitis, meningoencephalitis, myelitis, Guillain-Barre syndrome and acute disseminated encephalomyelitis (ADEM). Here we report a rare case of mycoplasma encephalitis in an adult who presented with a first episode
of seizure following fever and neck stiffness for one week. Mycoplasma pneumoniae antibody titer was markedly
elevated at >1:320 and MRI brain revealed encephalitic changes with a lesion in the splenium. Interestingly, there
was no associated respiratory infection and his stay in the hospital was also complicated by SIADH. The patient improved after treatment with a macrolide antibiotic.
10.Tissue Window versus Time Window? A Review of Patients Receiving Extended Hours Thrombolysis Guided By DWI-FLAIR Mismatch : Case Series
Anna Misya&rsquo ; il Abdul Rashid ; Mohamad Syafeeq Faeez Md Noh ; Abdul Hanif Khan Yusof Khan ; Wei Chao Loh ; Janudin Baharin ; Azliza Ibrahim ; Liyana Najwa Inche Mat ; Wan Aliaa Wan Sulaiman ; Fan Kee Hoo ; Hamidon Basri
Malaysian Journal of Medicine and Health Sciences 2022;18(No.3):182-187
Introduction: Intravenous thrombolysis (IVT) is the gold standard for the treatment of patients with acute ischemic
stroke (AIS) presenting within four and a half hours of onset. However, development of new thrombolytic agents and
advanced imaging has led to extended time for thrombolysis based on advanced imaging. Here we describe four
patients who presented in the extended hours; that benefitted from thrombolysis. Case series: We advocate magnetic resonance imaging (MRI) for AIS, that includes diffusion weighted imaging (DWI), apparent diffusion coefficient
(ADC), fluid attenuated inversion recovery (FLAIR), susceptibility weighted imaging (SWI), and magnetic resonance
angiography (MRA). We included four patients who were more than 18 years old, with National Institute of Health
Stroke Scale (NIHSS) of six or more, presenting between four and a half to nine hours after stroke onset with no contraindications for intravenous thrombolysis. The imaging criteria used to determine eligibility for IVT is evidence of
DWI-FLAIR mismatch on MRI. If FLAIR detects no signal change in the area of stroke on DWI, it is then termed DWIFLAIR mismatch, or FLAIR-negative – indicating high probability that the brain tissue is still viable, and that patients
are good candidates for IVT. Conclusion: For patients with AIS who present within nine hours, DWI-FLAIR mismatch
serves as an excellent surrogate marker of salvageable brain tissue, allowing a greater proportion of patients benefiting from this life-saving therapy. Our experience also shows that with careful patient selection, treatment with IVT
can safely be given without an increased risk of bleeding or mortality.